+1 915 229 3004 (U.S.) | 
+44 7452 242832 (U.K.)
+1 915 229 3004 (U.S.) | +44 7452 242832 (U.K.)
Global Guidewires Market Size was valued at USD 1.6 Billion in 2022. The Guidewires market industry is projected to grow from USD1.54 billion in 2023 to USD1.6 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 3.85% during the forecast period (2023 - 2032). Minimally invasive surgical procedures are becoming more and more popular as a result of advantages like smaller incisions, quicker healing, and reduced pain, as well as technological advancements and an increase in the number of elderly people who are susceptible to a number of chronic diseases like cardiovascular diseases, urological diseases, and neurovascular disorders,are the key market drivers enhancing the market growth.
Download Free Sample to learn more about this report
Source: Secondary Research, Primary Research, RESEARCH LAYER Database and Analyst Review
The popularity of minimally invasive surgery (MIS) is rising. These techniques lessen patient trauma and speed healing compared to invasive procedures like open heart surgery. Researchers' data that demonstrate how quickly open/invasive surgeries are being replaced with minimally invasive ones have been published by manufacturers (Ethicon Endo-Surgery, Inc.).
Unhealthy and evolving lifestyle patterns, such as consuming salt, saturated fats, and sweets; not exercising; abusing tobacco and alcohol; and not exercising, have increased the risk of developing chronic illnesses like obesity, cardiovascular disease, and metabolic disorders. The prevalence of cardiovascular, neurological, and urological problems is rising in part as a result of increasing rates of obesity, dietary aberrations, and smoking.
According to the WHO's 2018 estimate, 17.7 million people die each year as a result of cardiovascular diseases. Because of an increase in bad lifestyle choices like obesity and dietary aberrations, smoking, and other factors, the prevalence of cardiovascular disease is rising globally. The market is also expanding as a result of the steadily rising number of people suffering from congenital cardiac disease.
Guidewires are inserted to implant catheters, stents, and other medical devices. The growing number of catheter-associated infections that occur in hospitals is one issue that is projected to have an impact on catheter use. The growth of bacterial biofilm, especially in the case of indwelling catheters, is a factor in the development of diseases such catheter-associated urinary tract infections (CAUTI) and intravascular catheter-related infections.
It is projected that decreasing catheter use will have an impact on the market for guidewires as a result of growing public awareness of catheter-associated infections and their negative consequences on patients' quality of life. With the introduction of technological advancements targeted at limiting catheter-associated infections and FDA publications aimed at increasing knowledge about the proper use of catheters, it is projected that the market dynamics would move in favor of the guidewires market. Thus, driving the Guidewires market revenue.
The global Guidewires market segmentation, based on Product includes coronary, peripheral, urology, and neurovascular. Due to the increased demand for minimally invasive coronary operations, the coronary segment had the biggest revenue share at 44.8%. Hospital admissions of patients with atherosclerosis are significant, and the prevalence of cardiovascular disease is rising, both of which favor the segment's growth. According to the Heart Disease and Stroke Statistics 2018 study, about 92 million adult Americans had a cardiovascular disease in 2017.
The global Guidewires market segmentation,based on Coating, includes coated and non-coated. Due to strong demand, coated guidewire accounted for the majority of income. These materials reduce friction and maintain tactile sensitivity while facilitating simple access to blood vessels. There are coatings that are both hydrophilic and hydrophobic on the market. On the market are additional uncoated materials that are applied normally. However, the use of uncoated guidewires is rapidly declining as a result of the advantages that coated guidewires offer.
The global Guidewires market segmentation, based on Raw Materials, includes nitinol, stainless steel, and others. The majority of the revenue share in terms of raw materials was made up of stainless steel. Due to its qualities, including strong corrosion resistance combined with antibacterial, non-magnetic, and non-staining features, stainless steel is a highly favored raw material. Strong support, push force transfer, and torque standards are provided by stainless steel. Paragon Diagnostic Guidewire (Integer Holdings Corporation), Amplatz Support Wire Guide (Cook), and True Form Reshapable Guide Wire (Merit Medical Systems) are a few examples of goods made of stainless steel.
Download Free Sample to learn more about this report
Source: Secondary Research, Primary Research, RESEARCH LAYER Database and Analyst Review
Insights into the markets in North America, Europe, Asia-Pacific, and the rest of the world are provided by the study.North America had the biggest market share in terms of sales in 2022 (45.80%). The primary causes of this are the increasing prevalence of cardiovascular diseases and the rise in coronary and peripheral treatments. One of the primary factors driving up demand locally is the rise in popularity of minimally invasive procedures like cardiothoracic and coronary bypass surgery. Existence of market leaders like Terumo Medical Corporation, Boston Scientific Corporation, Abbott, Cardinal Health, AngioDynamics, and B. Braun Melsungen AG is another indication of the market's existing great potential.Further, In the North American area, the U.S. Guidewires market had the biggest market share, while the Canada Guidewires market had the quickest rate of expansion.
Further, the major countries studiedin the market reportare The U.S., Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Download Free Sample to learn more about this report
Source: Secondary Research, Primary Research, RESEARCH LAYER Database and Analyst Review
European surgeons are well respected throughout the world for their expertise in minimally invasive operations. France has constructed training facilities for these activities. As a safety measure, guidewires are used during minimally invasive coronary procedures. The use of technologically improved utilities for the treatment of target ailments, as well as favorable government policies, are some of the main drivers propelling market expansion in this area. On the European market, there are a number of significant competitors, including B. Braun Melsungen AG, Medtronic, Cook Medical, and Stryker.Further, In the European region, the German Guidewires market had the biggest market share, and the U.K. Guidewires market had the quickest rate of growth.
Asia Pacific is anticipated to experience a profitable CAGR over the course of the projection year due to factors like the rising senior population, the prevalence of cardiovascular disease, and the preference for cutting-edge minimally invasive surgery techniques that offer quicker results and higher accuracy. The business is also being boosted by unrealized potential in developing countries like China and India.Further, In the Asia-Pacific region, the Indian Guidewires market had the quickest rate of growth while China's Guidewires market had the greatest market share.
Leading industry companies are making significant R&D investments in order to diversify their product offerings, which will drive the Guidewires market's expansion. Important market developments include new product releases, contractual agreements, mergers and acquisitions, greater investments, and collaboration with other organizations. Market participants are also engaging in a number of strategic actions to increase their global footprint. The Guidewires sector needs to provide affordable products if it wants to grow and thrive in a more competitive and challenging market environment.
One of the primary business strategies employed by manufacturers in the worldwide Aerospace Foam industry to assist customers and expand the market sector is local manufacturing to reduce operational costs. Some of the biggest benefits to medicine have recently come from the Guidewires sector.Major players in the Guidewires market, including Olympus Corporation, Braun Melsungen AG, Abbott, Asahi Intecc, Co Ltd, Medtronic, Boston Scientific Corporation, Terumo Corporation, Stryker Corporation, Cook Group, AngioDynamicis Inc, and Cardinal Health, are attempting to increase market demand by investing in research and development operations.
A producer of medical devices, Cardiovascular Systems Inc. (CSI) develops and sells products for the management of coronary and peripheral vascular disease. The company offers coronary orbital atherectomy systems, peripheral orbital atherectomy systems, crowns, and accessories. It makes use of a percutaneous orbital atherectomy system as a type of treatment for OAS atherosclerotic disease in peripheral arteries. CSI offers other items such guide wires, lubricants, infusion pumps, and other accessories. It developed the orbital atherectomy system technology for both industrial applications in the coronary and peripheral arteries. Both peripheral arterial disease and coronary artery disease are assisted by the company. It uses a network of distributors to market its products to hospitals and clinics in the US. The headquarters of CSI are located in Saint Paul, Minnesota, a city in the United States. The U.S. FDA approved the pre-marketing of Cardiovascular Systems Inc.'s Viper Wire - Advance Coronary Guide Wire in October 2019. The introduction of this new product helped the company increase the variety of its offerings.
Cardiovascular Systems Inc. (CSI), a manufacturer of medical equipment, creates and markets solutions for the treatment of coronary and peripheral vascular disease. The business sells crowns, accessories, peripheral orbital atherectomy systems, and coronary orbital atherectomy systems. As a form of treatment for OAS atherosclerotic disease in peripheral arteries, it employs a percutaneous orbital atherectomy system. Guide wires, lubricants, infusion pumps, and other accessories are available from CSI. It created the orbital atherectomy system technology for use in coronary and peripheral arteries in industry. The company supports both peripheral arterial disease and coronary artery disease. It markets its goods to hospitals and clinics in the US through a network of distributors. In the American city of Saint Paul, Minnesota, CSI's headquarters are situated. In October 2019, the U.S. FDA authorized Cardiovascular Systems Inc.'s Viper Wire - Advance Coronary Guide Wire for pre-marketing. The launch of this new product assisted the business in diversifying its services. For access to distal lesions and additional backup support, Medtronic unveiled the Telescope Guide Extension Catheter in May 2019. This telescopic guide combines a hydrophilic coating at the distal end with a solid pushwire.
· Olympus Corporation
· Braun Melsungen AG
· Abbott
· Asahi Intecc, Co Ltd
· Medtronic
· Boston Scientific Corporation
· Terumo Corporation
· Stryker Corporation
· Cook Group
· AngioDynamicis Inc
· Cardinal Health
In April 2021: Boston Scientific Corporation has introduced the new KinetixTM Guidewire for percutaneous coronary intervention (PCI) treatments.
In January 2021: The value of Teleflex's ErgoPack® Complete upgrades to essential vascular access devices has been increased.
· Coronary
· Peripheral
· Urology
· Neurovascular
· Coated
· Non Coated
· Nitinol
· Stainless Steel
· Others
· North America
- U.S.
- Canada
· Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
· Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Australia
- Rest of Asia-Pacific
· Rest of the World
- Middle East
- Africa
- Latin America
|
Report Attribute/Metric |
Details |
|
Market Size 2022 |
USD 1.6 Billion |
|
Market Size 2023 |
USD 1.54 Billion |
|
Market Size 2032 |
USD 1.6 Billion |
|
Compound Annual Growth Rate (CAGR) |
3.85% (2023-2032) |
|
Base Year |
2022 |
|
Market Forecast Period |
2023-2032 |
|
Historical Data |
2018- 2022 |
|
Market Forecast Units |
Value (USDBillion) |
|
Report Coverage |
Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
|
Segments Covered |
Product, Coating,Raw Materials, and Region |
|
Geographies Covered |
North America, Europe, AsiaPacific, and the Rest of the World |
|
Countries Covered |
The U.S., Canada, German, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
|
Key Companies Profiled |
Olympus Corporation, Braun Melsungen AG, Abbott, Asahi Intecc, Co Ltd, Medtronic, Boston Scientific Corporation, Terumo Corporation, Stryker Corporation, Cook Group, AngioDynamicis Inc, and Cardinal Health |
|
Key Market Opportunities |
Increasing number of product launches |
|
Key Market Dynamics |
Rising preference for minimally invasive surgical procedures owing to advantages such as smaller incisions, faster recovery time, and reduced pain and technological advancements and rise in geriatric population prone to various chronic diseases such as cardiovascular diseases, urological diseases, and neurovascular disorders |
The global Guidewires Market was valued at USD 1.6 billion in 2022, and it is estimated to reach USD 1.6 billion by 2032.
The global market is projected to grow at a CAGR of 3.85% during the forecast period, 2023-2032.
North America had the largest share in the global market
The key players in the market are Olympus Corporation, Braun Melsungen AG, Abbott, Asahi Intecc, Co Ltd, Medtronic, Boston Scientific Corporation, Terumo Corporation, Stryker Corporation, Cook Group, AngioDynamicis Inc, and Cardinal Health.
The CoronaryProduct dominated the market in 2022.
The Coated guidewire had the largest share in the global market.
Report Code :
RL65111
Published on :
Aug 2023
Request a Free Sample Report
Speak to Analyst